期刊文献+

5-氟尿嘧啶对人胃癌细胞系p53β表达的影响 被引量:2

Influence of 5-fluorouracil on Expression of p53β in Gastric Carcinoma Cell Lines
下载PDF
导出
摘要 目的检测5-氟尿嘧啶(5-FU)对人胃癌细胞株MKN45及SGC-7901 p53,p53β表达的影响。方法将不同浓度5-FU作用细胞48h,用western-blot检测p53及P53β在蛋白水平表达的变化。结果 Westernblot结果显示,化疗药物5-FU作用MKN45胃癌细胞48h后,p53,P53β较未加药组表达增加,并且随药物浓度的增加其表达也随之增高,人正常胃黏膜细胞中p53,p53β的表达低于药物干预后的胃癌细胞;而相同条件下,在SGC-7901细胞系中,随药物浓度的增加p53,p53β的表达无明显变化。结论 5-FU能够抑制表达野生型p53人胃癌细胞系MKN45的增殖,并能上调p53,p53β的表达,推测p53β异构体参与的p53途径是5-FU诱导的肿瘤生长抑制的重要途径之一。5-FU能够抑制人胃中分化腺癌细胞SGC-7901的增殖,但与p53,p53β无明显关联。 Objective To explore the expression of p53β and its biological significance in 5-Fu treated gas- tric cancer cell lines. Methods MKN45 and SGC-7901 cells were cultured with 5-FU for two days,compare them with normal gastric mucosa cells and gastric; cancer cells without 5-FU ,western blot was used to detect the expression changes of p53,p53β. SPSS 17.0 software package was used for statistical analysis. P 〈 0.05 was determined to be significant difference. Results Western blot results showed that,with the increase concentration of 5-FU,the relative expression of p53 and p53β in MKN45 cells were increased remarkably,and the differences between the groups were statistically sig- nificant(P 〈0.05). In contrast,in SGC-7901 cell line,the expression of p53 and p53β were not change much with the increase of drug concentration. Conclusion In 5-FU can induce MKN45 gastric cancer cells proliferation inhibition,and the p53β plays as a cooperater with wide-type p53 ,inferring that p53β playes an important role in the inhibition effect of gastric cancer cell growth. The p53-p53β pathway may induce the proliferation inhibition in SGC-7901 cells, but the mechanism called for further exploration.
出处 《潍坊医学院学报》 2014年第1期57-59,共3页 Acta Academiae Medicinae Weifang
基金 山东省中青年科学家科研奖励基金(课题编号:BS2010SW034)
关键词 P53 p53β 5-氟尿嘧啶 野生型P53 突变型P53 p53 p5313 5-Fu Wild-type p53 Mutant p53
  • 相关文献

参考文献2

二级参考文献13

  • 1宋伟,吕家驹,方笑雷,夏庆华.p53β在肾细胞癌中的表达及其临床意义的研究[J].泌尿外科杂志(电子版),2010,2(1):17-20. 被引量:3
  • 2李卫泊,宋伟庆,张玉印,蔡建辉.5-氟尿嘧啶术前化疗对胃癌细胞凋亡和增殖的影响[J].中华肿瘤防治杂志,2006,13(14):1077-1079. 被引量:7
  • 3张良军 夏黎明.p53基因突变与胃癌关系的研究现状.中华现代临床学志,2008,6(8):491-493.
  • 4Yoshida K,Yaraaguchi K,Osada S,et al. Challenge for a better combi-nation with basic evidence[ J]. Int J Clin Oncol,2008 ,13(3) :212 -219.
  • 5Hainaut P,Hollstein M. P53 and human cancer:the first ten thousandmutations[ J]. Adv Cancer ,2000,77 (11) :81 --137.
  • 6Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the P53tumor sup-pressor gene: clues to cancer etiology and molecular patho-genesis [ J]. Cancer fies, 1994,54( 18) :4855 -4878.
  • 7Caceres JF,Komblihtt AR. Alternative splicing:multiple control mech-anisms and involvement in human disease[ J]. Trends Genet,2002,18(4):186 .193.
  • 8Anensen N,Oyan AM, Bourdon JC, et al. A distinct p53 protein iso-form signature reflects the onset of induction chemotherapy for acutemyeloid leukemia [J ]. Clin Cancer Res ,2006 ,12(13) :3985 .3992.
  • 9Krajewski S, Blomquist C, Franssila K, et al. Reduced expression ofproapopt-otic gene BAX is associated with poor response rates to com-bination chemotherapy and shorter survival in women with metastaticbreast adenocarcinoma[ J]. Cancer Res, 1995 ,55 (19) :4471 -4478.
  • 10Krajewska M,Moss S,Krajewski S,et al. Elevocted expression of Bel-x and reduced Bak in primary colorectal adenocarcinoma [ J ]. Cancerfe, 1996,56(10) :2422 .2427.

共引文献9

同被引文献66

  • 1张难,刘俊峰.P53、P21^(WAFI/CIP1)在食管癌中的表达及与临床特征和烟酒史的相关性的研究[J].食管外科电子杂志,2013(1):6-11. 被引量:2
  • 2唐炳华,王继锋.医学分子生物学[M].北京:中国中医药出版社,2010,265.
  • 3缪明永.p53突变或缺失与肿瘤代谢重编程[J].肿瘤代谢与营养电子杂志,2014,1(2):26-30.
  • 4LEE Y H, ANDERSEN J B, SONG H T, et al. Defi- nition of ubiquitination modulator COP1 as a novel therapeutic target in hunan hepatocellular carcinoma [J]. Cancer Research, 2010, 70:8264-8269.
  • 5Clegg H,Itahana K,Zhang Y.Unlocking the MDM22 p53 loop:Ubiquitin is the key[J].Cell Cycle,2008,7(3):287-292.
  • 6Nie X,Li M,Lu B,et al.Down-regulating overexpressed human Lon in cervical cancer suppresses cell proliferation and bioener-getics[J].PLoS One,2013,8:81-84.
  • 7Kate Huang,Lin Chen,Jiling Zhang.Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma[J].Oncol Let,2014,8:1441-1446.
  • 8Murata A,Baba Y,Watanabe M,et al.p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma[J].Med Oncol,2013,30:728.
  • 9Zhu HB,Yang K,Xie YQ,et al.Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells[J].World J Surg Onco,2013,1(11):22.
  • 10姜琳,孙灿林,焦霞,等.RNA干扰HCCR-2基因表达对食管癌EC9706细胞凋亡及周期的影响[J].中华临床医师杂志(电子版),2013,21:9619-9623.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部